Keywords: amarin, zelapar, approvable, usa, corp, parkinson, disease

Amarin's Zelapar approvable in USA

Article | 24 February 2003

Amarin Corp's Parkinson's disease drug Zelapar (selegiline HClorally-disintegrating tablets) has been deemed approvable by the US Food and Drug Administration. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Selegiline Hydrochloride

Zelapar

Go to drug listing